News & Press

01.08.2015

BMBF fördert die Entwicklung neuer Verfahren zur Charakterisierung von Antigen-Antikörper Wechselwirkungen als Grundlage für neue Therapeutika und Impfstoffe. (Kopie 2)

Regensburg, 01.08.2015 - In dem durch das BMBF BioChance Programm „KMU Innovativ“ geförderten Projekt will die Regensburger Firma 2Bind GmbH zusammen mit Prof. Ralf Wagner und seinem Team die MicroScale Thermophorese Technologie... > more

21.04.2015

Research Collaboration ForBIMed at "NACHT.SCHAFFT.WISSEN" in Regensburg, April 24, 2015

Regensburg, 21.04.2015 - The annual "NACHT.SCHAFFT.WISSEN" event is taking place on April 24 here in Regensburg and we are happy to announce our research collaboration ForBIMed will be participating. Our information... > more

06.03.2015

Regensburger Forschungsverbund "ForBIMed" im Rahmen der Bayerischen Forschungsallianz vertreten auf dem "Forum Life Science 2015"

Regensburg, 6.3.2015 - Die Bayerische Forschungsallianz auf dem Forum Life Science 2015 Auf dem neunten Forum Life Science, das am 11./12. März 2015 in München stattfindet, präsentiert die Bayerische Forschungsallianz (BayFOR)... > more

20.02.2015

Wagner team presenting at the 2015 Keystone Meeting in Banff, Canada

Regensburg, 20.2.2015 - The Wagner lab will be presented at the 2015 keystone meeting on HIV Pathogenesis and Vaccine development in Banff, Canada, with one oral and one poster presentation. Veronika Schmid will present her work... > more

19.02.2015

Wagner-Lab at the GfV conference, Bochum, March 2015

Regensburg, 19.2.2015 - The Wagner group will be actively participating in the 25th annual meeting of the Society of Virology (GfV) in Bochum 18-21.3.2015. Whilst Ralf Wagner will be co-chairing the plenary session on “Viral... > more

02.02.2015

University of Regensburg received additional Funding from the Bill and Melinda Gates foundation for the development of potential new therapeutic agents fighting AIDS

Regensburg, 2.2.2015 - The generation of HIV specific broad neutralizing antibodies (bNabs) occurs only in a minority (about 20%) of HIV infected subjects. The mechanisms preventing the generation of bNabs remain mostly unknown.... > more

05.01.2015

Ralf Wagner, University of Regensburg, appointed supervisory board member of Sirion Biotech GmbH, Munich

Martinsried, 5.1.2015 - Effective January 5th, Sirion Biotech appointed Ralf Wagner one out of 3 supervisory board members to support the management team regarding strategic directions. SIRION Biotech is a supplier of most... > more

Meetings

Upcoming Meetings
> more

Jobs

We permanently offer several opportunities for students to conduct research projects in the context of `Forschungs- und Schwerpunktpraktika´.
> more